| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.31▼ | 1.30▼ | 1.30▼ | 1.38▼ | 1.56▼ |
| MA10 | 1.31▼ | 1.30▼ | 1.32▼ | 1.44▼ | N/A |
| MA20 | 1.30▼ | 1.33▼ | 1.37▼ | 1.56▼ | N/A |
| MA50 | 1.32▼ | 1.37▼ | 1.42▼ | N/A | N/A |
| MA100 | 1.36▼ | 1.43▼ | 1.53▼ | N/A | N/A |
| MA200 | 1.38▼ | 1.55▼ | 1.60▼ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.001▲ | -0.004▼ | N/A | N/A |
| RSI | 43.551▼ | 35.412▼ | 33.215▼ | 29.193▼ | N/A |
| STOCH | 54.167 | 51.376 | 20.593 | 13.632▼ | N/A |
| WILL %R | -37.500 | -73.684 | -82.759▼ | -94.949▼ | N/A |
| CCI | -2.448 | -34.706 | -65.675 | -126.604▼ | N/A |
|
Thursday, May 07, 2026 06:23 AM
Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana Therapeutics”, the “Company”), a biotechnology company currently focused on developing therapies for Tuberous Sclerosis Complex (TSC)-related epilepsy, ...
|
|
Filana Therapeutics, Inc.: Filana Therapeutics Reports Q1 2026 Financial Results and Business Update
Thursday, May 07, 2026 05:40 AM
Filana Therapeutics, Inc. (NASDAQ: FLNA, "Filana Therapeutics", the "Company"), a biotechnology company currently focused on developing therapies for Tuberous ...
|
|
Tuesday, May 05, 2026 06:36 AM
Presentation described the biological rationale for the evaluation of simufilam in TSC-related epilepsyAUSTIN, Texas, May 05, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/05/26 | 1.35 | 1.35 | 1.275 | 1.30 | 419,594 |
| 07/05/26 | 1.42 | 1.435 | 1.345 | 1.36 | 521,850 |
| 06/05/26 | 1.36 | 1.47 | 1.35 | 1.44 | 476,947 |
| 05/05/26 | 1.43 | 1.44 | 1.36 | 1.38 | 595,542 |
| 04/05/26 | 1.51 | 1.51 | 1.40 | 1.40 | 460,345 |
| 01/05/26 | 1.44 | 1.575 | 1.44 | 1.51 | 819,131 |
| 30/04/26 | 1.44 | 1.48 | 1.39 | 1.45 | 566,735 |
| 29/04/26 | 1.56 | 1.56 | 1.43 | 1.44 | 416,730 |
| 28/04/26 | 1.57 | 1.5798 | 1.55 | 1.56 | 192,472 |
| 27/04/26 | 1.61 | 1.63 | 1.56 | 1.56 | 280,899 |
|
|
||||
|
|
||||
|
|